Exploring the Mechanisms of How Excess Androgens Adversely Impact Lipid Metabolism in Women with Polycystic Ovarian Syndrome

Exploring the Mechanisms of How Excess Androgens Adversely Impact Lipid Metabolism in Women with Polycystic Ovarian Syndrome

Saved in:

Bibliographic Details
Main Authors:	M. Wang, S. Proctor, M. Ghosh, D. Vine
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	CJC Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589790X25002653
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess
by: Francis de Zegher, et al.
Published: (2024-08-01)

Prevalence and Risk Factors of Metabolic Syndrome in Women with Polycystic Ovarian Syndrome
by: Zahra Waseem, et al.
Published: (2024-06-01)

The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome
by: Zhao Ting, et al.
Published: (2024-12-01)

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
by: Balachandran Kumarendran, et al.
Published: (2018-03-01)

Follicular development and endometrial receptivity of different androgen phenotypes in women with polycystic ovary syndrome
by: Xinling Wen, et al.
Published: (2024-12-01)

Progression of Atherosclerosis and Left Ventricular Dysfunction in High-Risk Young Women With and Without Polycystic Ovary Syndrome
by: X. Wu, et al.
Published: (2025-06-01)

The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism
by: Xueming Huang, et al.
Published: (2025-06-01)

Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome
by: Yishu Wang, et al.
Published: (2025-08-01)

Is serum amylase normal in women with polycystic ovarian syndrome?
by: Baghdad Science Journal
Published: (2014-12-01)

Association of Polycystic Ovarian Syndrome Features and Metabolic Syndrome Among Reproductive-Aged Women in the United States
by: Deepali K. Ernest, et al.
Published: (2025-01-01)

Effect of Oligopin Administration on Ovarian Morphology in Women with Polycystic Ovarian Syndrome (PCOS)
by: Sayed Mahmoud Sajjadi-Jazi, et al.
Published: (2024-01-01)

POLYCYSTIC OVARIAN SYNDROME
by: T. D. Guriev
Published: (2016-08-01)

Epiregulin dysregulation in polycystic ovary syndrome: metabolic and ovarian implications
by: Zainab Ghazi Mohammed, et al.
Published: (2025-05-01)

PECULIARITIES OF STIMULATION OF OVULATION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME OF DIERENT AGE
by: M. P. Mironova, et al.
Published: (2016-06-01)

Heart Health in Young Women: Progression of Atherosclerotic Cardiovascular Disease Is Increased In Those With Polycystic Ovary Syndrome
by: X. Wu, et al.
Published: (2025-06-01)

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study
by: Manman Pan, et al.
Published: (2023-08-01)

Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study
by: Swati Dhar, et al.
Published: (2024-01-01)

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome
by: Ruihan Wang, et al.
Published: (2025-01-01)

BCAA metabolism: the Achilles’ heel of ovarian cancer, polycystic ovary syndrome, and premature ovarian failure
by: Tian Zeng, et al.
Published: (2025-07-01)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
by: Ying Huang, et al.
Published: (2014-01-01)

THE PECULIARITIES OF ORAL CAVITY ENZYME FUNCTIONING IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
by: J.G. Romanova, et al.
Published: (2018-03-01)

Management Infertility by Hormones Replacement Therapy in Women with Polycystic Ovarian Syndrome
by: Sardar Qadir Omer, et al.
Published: (2020-06-01)

Natural History of Cardiovascular Disease in Young Women: Cardiometabolic Risk, Atherosclerotic Cardiovascular Disease and Cardiac Function Is Exacerbated in Those With Polycystic Ovary Syndrome
by: X. Wu, et al.
Published: (2025-06-01)

Significance of androgen receptor and its potential for anti-androgen/androgen receptor-antagonist therapy in ovarian cancers.
by: Teresa H Kim, et al.
Published: (2025-01-01)

Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome
by: Sukirti Misra, et al.
Published: (2025-05-01)

Determination of insulin resistance, adiponectin and leptin in overweight women with polycystic ovarian syndrome
by: Sara Sardar Hamad, et al.
Published: (2025-08-01)

The influence of combined antioxidants usage on periodontal pathology in women with polycystic ovarian syndrome
by: Yu. G. Romanova, et al.
Published: (2018-04-01)

Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome
by: Lulu Geng, et al.
Published: (2025-05-01)

Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
by: Yuqin Zhang, et al.
Published: (2025-07-01)

OVARIAN RESERVE IN THE WOMEN OF LATE REPRODUCTIVE AGE AFTER CONSERVATIVE TREATMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS) IN ADOLESCENCE
by: K. G. Beltadze, et al.
Published: (2016-06-01)

Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
by: Qianqian Yin, et al.
Published: (2021-01-01)

Comparative analysis of laser ovarian drilling in surgical management of polycystic ovarian syndrome
by: E. S. Aghajanyan, et al.
Published: (2016-12-01)

Clinical presentation, hormonal profiles in nulliparous Korean women with polycystic ovarian morphology
by: Y.J. Shin, et al.
Published: (2020-06-01)

Comparison Of Glucagon Like Peptide/1 Levels In Diabetic Women With Ovarian Polycystic Syndrome And Healthy Women
by: Namra Iqtidar, et al.
Published: (2024-09-01)

Detection of Type 2 Diabetes Mellitus in Serum from Women with Polycystic Ovarian Syndrome
by: Baghdad Science Journal
Published: (2013-06-01)

The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment
by: Sotirios Pililis, et al.
Published: (2024-10-01)

Effect of Weight Loss on Symptoms of Polycystic Ovarian Syndrome among Women of Reproductive Age
by: Anita Dileep, et al.
Published: (2021-04-01)

Assessment of Intestinal Hormones Cholecystokinin and Peptide YY in Iraqi Women with Polycystic Ovarian Syndrome.
by: Mariam A. Malik, et al.
Published: (2025-04-01)

Features of correction of metabolic disorders in women with polycystic ovary syndrome
by: O.V. Bulavenko, et al.
Published: (2024-10-01)

Exploring the therapeutic potential of Asparagus africanus in polycystic ovarian syndrome: a computational analysis
by: Riaz Sania, et al.
Published: (2024-12-01)